Core Viewpoint - Shenzhen Huatai Medical Devices Co., Ltd. will participate in the 2024 annual performance briefing for the medical device industry on April 25, 2025, to discuss its operational results, financial status, cash dividend plan, and development strategy with investors [2][3][4]. Group 1: Event Details - The performance briefing is scheduled for April 25, 2025, from 15:00 to 17:00 [4]. - The event will take place at the Shanghai Stock Exchange Roadshow Center and will be conducted in an online text interaction format [4][5]. - Investors can submit questions via email or phone by April 24, 2025, to have their inquiries addressed during the briefing [5]. Group 2: Participants - Key participants include Chairman Ge Hao, Vice General Manager and Financial Officer Dai Zhenhua, and Independent Director Xia Lijun [4]. Group 3: Accounting Policy Change - The company announced a change in accounting policies in accordance with the Ministry of Finance's new guidelines, effective January 1, 2024, which will not affect previously disclosed financial statements or the company's financial status [9][10][11]. - The changes include the implementation of new accounting standards regarding the classification of current and non-current liabilities, supplier financing arrangements, and accounting for sale-leaseback transactions [10][11].